Cerbios joins Swiss presence at BIO International

Lugano, Switzerland:- Pharmaceutical ingredient specialist Cerbios-Pharma SA (Cerbios) will be a key part of a high-profile Swiss presence in California for the big BIO International Convention in San Diego.

Cerbios will use the event to present advantages for its exclusive contract manufacturing (CMO) services that include highly potent active ingredients (HPAPIs), fully integrated Antibody Drug Conjugate (ADC) services, modified antibodies (mAbs) and recombinant protein (Rec. Prot.) development.

Swiss -Biotech

Cerbios will be a key part of the Swiss Biotech Association presence at stand 2305 within the Swiss Pavilion and as part of a full hospitality program covering all four days of the event. This includes special education sessions, a Global Innovation Hub presentation and a ticket-only reception for key industry players at the nearby Tom Ham’s Lighthouse on the Tuesday evening, June 20.

Swiss Biotech pre-event marketing headlines Cerbios membership of the PROVEO Alliance, completing a pan-European consortium that can offer a highly integrated ADC manufacturing capability. Cerbios also features prominently in the Swiss Biotech Report 2017 commissioned for the event.

CMO capabilities

“We are looking forward to meeting other leading biopharma players from around the world at BIO International,” said Cerbios-Parma CCO, Dr. Denis Angioletti.

“This is one of the world’s leading platforms for meeting our customers and potential customer forging new strategic alliances and partnerships, as well as a key opportunity to present the full range of very interesting manufacturing capabilities we can now offer,” said Dr. Angioletti.

“With over 40 years of expertise, we are extending our activities and our proficiency in HPAPIs, Probiotics and Recombinant products. Our CMO offers now include ADC manufacturing capabilities enhanced by synergies between our Chemical and Biological divisions and turned into a fully integrated service by our membership of the PROVEO Alliance with partners in USA, Denmark and Germany,” Dr. Angioletti added.

About Cerbios-Pharma

Cerbios-Pharma SA is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacture of both chemical and biological APIs for its partners worldwide. Cerbios specializes in the development and production of high potency active pharmaceutical ingredients (HPAPIs) in the area of fine chemicals and biologicals.

Cerbios Chemical Division offers exclusive, third party manufacturing services for HPAPIs while Biological Division produces monoclonal antibodies, recombinant proteins and pharma probiotics.

Cerbios provides full CMC support to its worldwide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA, Japan and India.

Since 2015, Cerbios has been a member of the ADC manufacture PROVEO™ consortium, forged with CMC Biologics of Denmark, together with Germany’s Oncotec and IDT Biologika. PROVEO can offer a one-stop shop service from substance development through to full finish.

About BIO International

The BIO International Convention (BIO) provides a week of intensive networking for biotechnology and pharma leaders to discover new opportunities and promising partnerships. It attracts more than 16,000 delegates involved in a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.

BIO International 2017 is a four -day event opening June 19 at the harbor-side San Diego Convention Center in southern California. The convention will feature more than 35,000 face-to-face meetings for some 3,100 companies organised using the proprietary BIO One-on-One partnering™ system, as well as hundreds of individual company presentations, a program of world-renowned keynote speakers and some 20 Session Tracks.

A co-located trade show will feature more than 1,800 exhibitors from fields ranging from digital health and diagnostics to bioprocesses.

The event is organized by the Washington DC-based Biotechnology Innovation Organization with more information at: http://convention.bio.org/.